Dr John Peter Campbell, MD, MPH | |
3375 Sw Terwilliger Blvd, Portland, OR 97239-4146 | |
(503) 494-3000 | |
(503) 494-7286 |
Full Name | Dr John Peter Campbell |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 15 Years |
Location | 3375 Sw Terwilliger Blvd, Portland, Oregon |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1255598041 | NPI | - | NPPES |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Oregon Health And Sciences University/university Medical Group | 4880760107 | 1485 |
Oregon Health And Sciences University/university Medical Group | 4880760107 | 1485 |
News Archive
UAB researchers have identified a therapeutic target for the treatment of acute spinal cord injuries. According to this research, conducted on mice, the administration of a drug that prevents loss of myelin - the insulating sheath around nerve fibres that allows signals to be transmitted - increases the mobility of the mice after an injury.
In recent years, improvements in cancer therapy have led to a significant increase in cancer survivorship. Experts estimate that by 2022, the United States will have 18 million cancer survivors, but a subset of those survivors will have long-term health problems to be addressed.
Researchers at Columbia University recently analyzed the positive effects of Modified Citrus Pectin (MCP) on human and mouse prostate cancer cell lines. The results, as reported by lead researcher Dr. Aaron Katz in the publication of Integrative Cancer Therapies, show that MCP inhibits cell proliferation and induces apoptosis (programmed cell death) in both androgen-dependent and androgen-independent cancer cells in a time and dose-dependent manner.
Implementing a well-established business approach allowed physicians to shave hours off pediatric patient discharges without affecting readmission rates, according to researchers at Penn State Hershey Children's Hospital.
› Verified 7 days ago
Entity Name | University Professional Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1376709535 PECOS PAC ID: 4880760107 Enrollment ID: O20080910000013 |
News Archive
UAB researchers have identified a therapeutic target for the treatment of acute spinal cord injuries. According to this research, conducted on mice, the administration of a drug that prevents loss of myelin - the insulating sheath around nerve fibres that allows signals to be transmitted - increases the mobility of the mice after an injury.
In recent years, improvements in cancer therapy have led to a significant increase in cancer survivorship. Experts estimate that by 2022, the United States will have 18 million cancer survivors, but a subset of those survivors will have long-term health problems to be addressed.
Researchers at Columbia University recently analyzed the positive effects of Modified Citrus Pectin (MCP) on human and mouse prostate cancer cell lines. The results, as reported by lead researcher Dr. Aaron Katz in the publication of Integrative Cancer Therapies, show that MCP inhibits cell proliferation and induces apoptosis (programmed cell death) in both androgen-dependent and androgen-independent cancer cells in a time and dose-dependent manner.
Implementing a well-established business approach allowed physicians to shave hours off pediatric patient discharges without affecting readmission rates, according to researchers at Penn State Hershey Children's Hospital.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr John Peter Campbell, MD, MPH 3375 Sw Terwilliger Blvd, Portland, OR 97239-4146 Ph: (503) 494-7891 | Dr John Peter Campbell, MD, MPH 3375 Sw Terwilliger Blvd, Portland, OR 97239-4146 Ph: (503) 494-3000 |
News Archive
UAB researchers have identified a therapeutic target for the treatment of acute spinal cord injuries. According to this research, conducted on mice, the administration of a drug that prevents loss of myelin - the insulating sheath around nerve fibres that allows signals to be transmitted - increases the mobility of the mice after an injury.
In recent years, improvements in cancer therapy have led to a significant increase in cancer survivorship. Experts estimate that by 2022, the United States will have 18 million cancer survivors, but a subset of those survivors will have long-term health problems to be addressed.
Researchers at Columbia University recently analyzed the positive effects of Modified Citrus Pectin (MCP) on human and mouse prostate cancer cell lines. The results, as reported by lead researcher Dr. Aaron Katz in the publication of Integrative Cancer Therapies, show that MCP inhibits cell proliferation and induces apoptosis (programmed cell death) in both androgen-dependent and androgen-independent cancer cells in a time and dose-dependent manner.
Implementing a well-established business approach allowed physicians to shave hours off pediatric patient discharges without affecting readmission rates, according to researchers at Penn State Hershey Children's Hospital.
› Verified 7 days ago
Amy Ying Tong, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1955 Nw Northrup St, Portland, OR 97209 Phone: 503-227-2020 | |
Sungjae Yang, Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3375 Sw Terwilliger Bld, Casey Eye Institue, Portland, OR 97239 Phone: 503-494-5023 | |
Dr. Michael David Straiko, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1040 Nw 22nd Ave., Suite 200, Portland, OR 97210 Phone: 503-413-8202 Fax: 503-413-6937 | |
Allison Rebecca Loh, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 3375 Sw Terwilliger Blvd, Portland, OR 97239 Phone: 503-494-3000 Fax: 503-494-4286 | |
John Carl Morrison, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3303 Sw Bond Ave, Portland, OR 97239 Phone: 503-494-3000 Fax: 503-418-0843 | |
Adam Marcus Hanif, Ophthalmology Medicare: Medicare Enrolled Practice Location: 3181 Sw Sam Jackson Park Rd, Portland, OR 97239 Phone: 503-494-3000 Fax: 503-494-4286 | |
Mr. John Jah-hyun Koo, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3600 N. Interstate Avenue, Department Of Opthalmology, Portland, OR 97227 Phone: 503-331-6330 Fax: 503-571-5877 |